Trial · NCT03467425
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 1,545 | |
| Overall Study | STARTED | Non-ELLIPTA MITT | 1,547 | |
| Overall Study | Randomized But Did Not Start IP | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 1 | |
| Overall Study | Randomized But Did Not Start IP | Non-ELLIPTA MITT | 0 | |
| Overall Study | Completed IP | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 1,256 | |
| Overall Study | Completed IP | Non-ELLIPTA MITT | 1,359 | |
| Overall Study | Not Completed IP | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 288 | |
| Overall Study | Not Completed IP | Non-ELLIPTA MITT | 188 | |
| Overall Study | Withdrew IP (WIP): Lost to Follow-up | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 15 | |
| Overall Study | Withdrew IP (WIP): Lost to Follow-up | Non-ELLIPTA MITT | 24 | |
| Overall Study | WIP: Protocol Deviation | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 0 | |
| Overall Study | WIP: Protocol Deviation | Non-ELLIPTA MITT | 2 | |
| Overall Study | WIP: Adverse Event | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 112 | |
| Overall Study | WIP: Adverse Event | Non-ELLIPTA MITT | 29 | |
| Overall Study | WIP: Lack of Efficacy | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 56 | |
| Overall Study | WIP: Lack of Efficacy | Non-ELLIPTA MITT | 28 | |
| Overall Study | WIP: Physician Decision | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 14 | |
| Overall Study | WIP: Physician Decision | Non-ELLIPTA MITT | 27 | |
| Overall Study | WIP: Withdrawal by Participant | FF /UMEC/VI: 100 mcg/62.5 mcg/25 mcg by ELLIPTA DPI | 91 | |
| Overall Study | WIP: Withdrawal by Participant | Non-ELLIPTA MITT | 78 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03467425/flow